MN-10-T

DRUG2 trials

Sponsors

Asahi Kasei Pharma Corporation

Conditions

Osteoporosis

Phase 1

Clinical Study of AK159 in Healthy Postmenopausal Women

CompletedNCT01551602

Asahi Kasei Pharma CorporationOsteoporosis

Start: 2012-03-31End: 2012-10-31Updated: 2016-07-25

A Phase I Study of AK159 in Healthy Postmenopausal Women

CompletedNCT01935479

Asahi Kasei Pharma CorporationOsteoporosis

Start: 2013-08-31End: 2014-02-28Target: 170Updated: 2017-02-15